MedTrace Logo

Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating

NCT02104167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2019-04-16

Study results available
· View outcomes & findings →

Summary

The purpose of this combined retrospective and prospective clinical study is to examine the clinical outcomes of the ROI-C® anterior cervical interbody fusion device with VerteBRIDGE® plating to treat single level degenerative disc disease between C2 and T1 in the short term, with a focus on fusion rates.

Conditions

  • Degenerative Disc Disease

Interventions

DEVICE

ROIC interbody cage with VerteBRIDGE plating

Sponsors & Collaborators

  • LDR Spine USA

    lead INDUSTRY

Principal Investigators

  • Robert J Jackson, MD · Orange County Neurosurgical Associates

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-04-30
Completion
2015-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02104167 on ClinicalTrials.gov